Literature DB >> 22572612

Case fatality associated with a hypervirulent strain in patients with culture-positive Clostridium difficile infection: a retrospective population-based study.

Reetta Huttunen1, Risto Vuento, Jaana Syrjänen, Päivi Tissari, Janne Aittoniemi.   

Abstract

BACKGROUND: Clostridium difficile is a major infectious cause of healthcare-associated diarrhea. The epidemiology of C. difficile infection (CDI) is changing, with evidence of increased incidence and severity. The first patient with a hypervirulent strain type in Pirkanmaa Hospital District, Finland was reported in September 2008.
METHODS: We reviewed all culture-positive C. difficile episodes that occurred in Pirkanmaa Hospital District during the period September 2008 to May 2010.
RESULTS: A total of 780 episodes of C. difficile occurred in 622 patients. A hypervirulent strain caused 14.2% of all episodes. The day 30 case fatality associated with CDI was 8.5% in episodes with a non-hypervirulent strain and 20.7% in episodes with a hypervirulent strain type (p<0.001, odds ratio 2.8, 95% confidence interval 1.6-4.8). The median age among those infected by a hypervirulent strain was higher than among those infected by a non-hypervirulent strain (83 vs. 75 years, p<0.001). Hypervirulent strain type remained a significant factor associated with case fatality in a logistic regression model. Blood leukocytes were significantly higher in episodes due to a hypervirulent strain (11.0 vs. 9.4 × 10(9)/l, p=0.007). Blood leukocytes and C-reactive protein (CRP) on the day of diagnosis were significantly higher in non-survivors compared to survivors in CDI (13.2 vs. 9.6 × 10(9)/l, p=0.009, and 106.0 vs. 79.4 mg/l, p<0.001, respectively).
CONCLUSIONS: Infection due to a hypervirulent strain is a factor associated with increased case fatality in CDI. Blood leukocytes are significantly higher in CDI caused by a hypervirulent strain. Leukocyte count and CRP are useful prognostic biomarkers in patients with CDI.
Copyright © 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22572612     DOI: 10.1016/j.ijid.2012.02.019

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  3 in total

1.  Epidemiology of Clostridium difficile infection: results of a hospital-based study in Krakow, Poland.

Authors:  J Czepiel; J Kędzierska; G Biesiada; M Birczyńska; W Perucki; P Nowak; A Garlicki
Journal:  Epidemiol Infect       Date:  2015-04-10       Impact factor: 4.434

2.  Selection of nanobodies that block the enzymatic and cytotoxic activities of the binary Clostridium difficile toxin CDT.

Authors:  Mandy Unger; Anna Marei Eichhoff; Lucas Schumacher; Moritz Strysio; Stephan Menzel; Carsten Schwan; Vanina Alzogaray; Vanesa Zylberman; Michel Seman; Johanna Brandner; Holger Rohde; Kai Zhu; Friedrich Haag; Hans-Willi Mittrücker; Fernando Goldbaum; Klaus Aktories; Friedrich Koch-Nolte
Journal:  Sci Rep       Date:  2015-01-19       Impact factor: 4.379

Review 3.  Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review.

Authors:  Claire Nour Abou Chakra; Jacques Pepin; Stephanie Sirard; Louis Valiquette
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.